Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › New Jersey
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in New Jersey
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in New Jersey.
Cities in New Jersey
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT04301076A Registry for People With T-cell Lymphoma
- Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
- Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT06698003From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.